KPX Lifescience.Co.Ltd Capital Reinvestment Ratio
KPX Lifescience.Co.Ltd capital reinvestment ratio. KPX Lifescience.Co.Ltd (114450) has a Capital Reinvestment Ratio of 0.08x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩3.33 Billion) in capital expenditures (₩275.98 Million). Check KPX Lifescience.Co.Ltd (114450) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of KPX Lifescience.Co.Ltd (2014–2024)
Capital reinvestment ratio of KPX Lifescience.Co.Ltd from 2014 to 2024. This chart tracks KPX Lifescience.Co.Ltd's Capital Reinvestment Ratio across 10 annual periods. Also explore KPX Lifescience.Co.Ltd (114450) net asset momentum to track the company's year-over-year net asset growth rate.
KPX Lifescience.Co.Ltd Capital Reinvestment Ratio by Year (2014–2024)
KPX Lifescience.Co.Ltd capital reinvestment ratio by year from 2014 to 2024. For the full cash flow conversion analysis, see 114450 cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.88x | ₩525.49 Million | ₩462.71 Million | ▼ -31.4% |
| 2023 | 1.28x | ₩370.02 Million | ₩475.02 Million | ▼ -77.2% |
| 2021 | 5.63x | ₩611.38 Million | ₩3.44 Billion | ▲ +301.7% |
| 2020 | 1.40x | ₩1.90 Billion | ₩2.67 Billion | ▲ +65.2% |
| 2019 | 0.85x | ₩4.24 Billion | ₩3.60 Billion | ▼ -39.0% |
| 2018 | 1.39x | ₩5.38 Billion | ₩7.49 Billion | ▲ +83.6% |
| 2017 | 0.76x | ₩5.68 Billion | ₩4.31 Billion | ▲ +234.5% |
| 2016 | 0.23x | ₩7.07 Billion | ₩1.60 Billion | ▲ +141.7% |
| 2015 | 0.09x | ₩5.62 Billion | ₩526.82 Million | ▼ -54.3% |
| 2014 | 0.21x | ₩4.09 Billion | ₩838.78 Million | — |